(Q40599916)
Statements
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines (English)
Pfreundschuh M
Hartmann F
Renner C
Jung W
da Costa L
Tembrink S
Held G
Sek A
Bauer S